But clinical trials may offer hope. Hope for potentially life-changing medicines — here's how. Over the past two decades, the U.S. Food and Drug Administration (FDA) has approved more than 900 new ...

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

Maged Henary's cancer-fighting technology, developed in collaboration with a former Emory professor, is the first Georgia State-backed technology to advance to human clinical trials.

Fate Therapeutics, Inc. FATE presented encouraging initial clinical and translational data from the first patient treated in ...

A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...

When making diagnostic decisions, radiologists and other physicians may rely too much on artificial intelligence (AI) when it ...

"AHA 2024: Muvalaplin shows promising Phase II results for elevated serum lipoprotein (a)" was originally created and ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

I am midway through my conversation with Paul Siegel when it hits him: he needs to feed his spider. The tarantula in question ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

A clinical trial by University College London (UCL) and the University of Sheffield found that robotic surgery reduced the ...